A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Clinical trial NCT01606761 · COMPLETED
Trial details
- NCT number
- NCT01606761
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-06
- Primary completion
- 2015-03-17
- Enrollment
- 878
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.